Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
25.02
1.34 (5.66%)
BSENSE

Aug 12, 03:30 PM

BSE+NSE Vol: 2.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryKabra Drugs VS Pharmaceuticals & Biotechnology
 
1D
5.66%
-0.24%
1W
4.38%
-0.78%
1M
15.3%
0.51%
YTD
-18.1%
-8.51%
1Y
19.71%
-2.83%
3Y
381.15%
19.36%
5Y
%
42.16%
10Y
%
176.94%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.95%
0%
-3.95%
6 Months
-24.84%
0%
-24.84%
1 Year
19.71%
0%
19.71%
2 Years
187.26%
0%
187.26%
3 Years
381.15%
0%
381.15%
4 Years
473.85%
0%
473.85%
5 Years
0%
0%
0.0%

Kabra Drugs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available